Last update 01 Nov 2024
Jiangsu Durui Pharmaceutical Co. Ltd.
Private Company|
2010|
Jiangsu Sheng, China
Last update 01 Nov 2024
Overview
Basic Info
Introduction Jiangsu Durui Pharmaceutical Co. Ltd. is a privately-owned business based in China that specializes in the production of pharmaceutical goods. |
Tags
Other Diseases
Hemic and Lymphatic Diseases
Nervous System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价他替瑞林片在中国成年健康受试者中的一项单中心、随机、开放、空腹/餐后单次给药、两制剂、两周期、双交叉的生物等效性研究
[Translation] A single-center, randomized, open-label, single-dose, fasting/fed, two-dose, two-period, double-crossover bioequivalence study to evaluate the efficacy of talactirelin tablets in healthy adult Chinese subjects
吗替麦考酚酯胶囊在健康受试者中随机、开放、单剂量、双周期、双交叉空腹和餐后状态下的生物等效性试验
[Translation] A randomized, open-label, single-dose, two-period, double-crossover bioequivalence study of mycophenolate mofetil capsules in healthy subjects under fasting and fed conditions
吗替麦考酚酯胶囊在健康受试者中随机、开放、单剂量、双周期、双交叉空腹和餐后状态下的生物等效性试验
[Translation] A randomized, open-label, single-dose, two-period, double-crossover bioequivalence study of mycophenolate mofetil capsules in healthy subjects under fasting and fed conditions
100 Clinical Results associated with Jiangsu Durui Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangsu Durui Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Durui Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Approved
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free